These authors contributed equally.
Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study
Article first published online: 8 SEP 2013
Published 2013. This article is a U.S. Government work and is in the public domain in the USA
Clinical & Experimental Immunology
Volume 174, Issue 1, pages 120–128, October 2013
How to Cite
Price, J. D., Linder, G., Li, W. P., Zimmermann, B., Rother, K. I., Malek, R., Alattar, M. and Tarbell, K. V. (2013), Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study. Clinical & Experimental Immunology, 174: 120–128. doi: 10.1111/cei.12144
- Issue published online: 8 SEP 2013
- Article first published online: 8 SEP 2013
- Accepted manuscript online: 27 MAY 2013 07:50AM EST
- Manuscript Accepted: 21 MAY 2013
Fig. S1. Change in neutrophil percentage (top) and absolute count per µl (bottom) were measured in participants in both the sitagliptin group (left) and placebo group (right). No significant changes were observed between placebo and sitagliptin groups (P = 0·41 for percentage and P = 0·59 for absolute number change from days 0 to 28).
Table S1. Demographic characteristics of study subjects (n = 36).
Table S2. Significant (P < 0·001) genes changed greater than 1·2-fold after sitagliptin or placebo treatment.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.